Text Size

Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer

This study has been terminated.
(The PI is no longer with Kentuckiana Cancer Institute. All current subjects completed. No further subjects will be enrolled. Terminated with IRB.)
Sponsor:
Information provided by:
Kentuckiana Cancer Institute
ClinicalTrials.gov Identifier:
NCT00283530
First received: January 26, 2006
Last updated: January 18, 2010
Last verified: January 2010
History of Changes
  Purpose

The purpose of this study is to identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.


Condition Intervention
Cancer
 Procedure: Tumor biopsy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Identification of Tumor Phenotypes and Correlation to Clinical Outcomes in Patients Diagnosed With Cancer

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Kentuckiana Cancer Institute:

Estimated Enrollment: 1000
Study Start Date: May 2003
Study Completion Date: July 2009
Detailed Description:

To identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Cancer subjects who have or will have tissue and or blood collected.

Criteria

Inclusion Criteria:

  • Diagnosis of cancer receiving chemotherapy
  • Have had or will have tissue and/or blood samples collected
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00283530

Locations
United States, Kentucky
Kentuckiana Cancer Institute
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
Kentuckiana Cancer Institute
Investigators
Study Director: Shawn D. Glisson, MD Kentuckiana Cancer Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00283530     History of Changes
Other Study ID Numbers: 1050203, CPTAIV-0020-385
Study First Received: January 26, 2006
Last Updated: January 18, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Kentuckiana Cancer Institute:
Cancer
Cancer receiving chemotherapy
Tumor biopsy

ClinicalTrials.gov processed this record on May 21, 2013